Dentsply Sirona appoints John Fortson as EVP & CFO; base salary $780K

DENTSPLY SIRONA Inc.

John Fortson named EVP & CFO effective July 20, 2026; previously CFO at Kymera International and CEO at Ingevity.
Compensation includes $780K base salary, 85% target bonus, $500K sign-on cash (Feb 2027), and $700K sign-on equity.
Sign-on equity 60% premium stock options, 40% RSUs, three-year ratable vesting.
Employment subject to severance plans and two-year non-compete agreement.
Fortson brings 25+ years of finance and operations leadership experience.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John C. Fortson

Executive Vice President & Chief Financial Officer

XRAY · DENTSPLY SIRONA Inc.

Effective: 2026-07-20
Filed: June 11, 2026, 8:32 AM ET

On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John C. Fortson was appointed as Executive Vice President & Chief Financial Officer at DENTSPLY SIRONA Inc..

Action: appointed
Role: Executive Vice President & Chief Financial Officer

Exact text from the filing

On June 1, 2026, the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) appointed John C. Fortson as the Company’s Executive Vice President & Chief Financial Officer, effective as of July 20, 2026 (the “Effective Date”).

View on SEC.gov

DENTSPLY SIRONA Inc. filing history →

Source: SEC EDGAR

accession 0000818479-26-000200

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.